REPRODUCTIVE HEALTH DRUGS ADVISORY COMMITTEE
April 10, 2000
Food and Drug Administration Briefing Package Table of Contents
Letter to the Committee Members from Deputy Director, Division of Reproductive Health and Urologic Drug Products, FDA
FDA Review Package for the Advisory Committee
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
TAP Holdings Inc Briefing Information